13D Filing: Farallon Capital and Nexvet Biopharma PLC (NVET)

Page 33 of 68

Page 33 of 68 – SEC Filing

SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
Dated:  April 18, 2017
/s/ Monica R. Landry
FARALLON CAPITAL MANAGEMENT, L.L.C.,
On its own behalf and
As the Manager of
AKUBRA INVESTORS, LLC,
BUSHRANGER FUNDING, LLC and
UTE HOLDINGS, LLC
By Monica R. Landry, Managing Member
/s/ Monica R. Landry
FARALLON PARTNERS, L.L.C.
By Monica R. Landry, Managing Member
/s/ Monica R. Landry
NGP, L.L.C.
By Farallon Capital Management, L.L.C., its Manager
By Monica R. Landry, Managing Member
/s/ Monica R. Landry
FARALLON AA GP, L.L.C.
By Monica R. Landry, Manager
/s/ Monica R. Landry
FARALLON PARTNERS GP VI, L.L.C.
By Monica R. Landry, Manager
/s/ Monica R. Landry
Monica R. Landry, individually and as attorney-in-fact for each of Philip D. Dreyfuss, Michael B. Fisch, Richard B. Fried, Daniel J. Hirsch, David T. Kim, Michael G. Linn, Ravi K. Paidipaty, Rajiv A. Patel, Thomas G. Roberts, Jr., William Seybold, Andrew J. M. Spokes, John R. Warren and Mark C. Wehrly
The Powers of Attorney executed by each of Fisch, Fried, Hirsch, Kim, Linn, Patel, Roberts, Spokes, Warren and Wehrly authorizing Landry to sign and file this Schedule 13D on his behalf, which were filed as exhibits to the Schedule 13D filed with the SEC on August 26, 2014 by such Reporting Persons with respect to the Common Stock of Town Sports International Holdings Inc., are hereby incorporated by reference. The Powers of Attorney

Follow Nexvet Biopharma Plc (NASDAQ:NVET)

Page 33 of 68